SR9009 / Stenabolic (20mg Research Vial)
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
What it is: SR9009 (Stenabolic) is a synthetic small-molecule agonist of Rev-ErbAα and Rev-ErbAβ, nuclear hormone receptors that orchestrate the mammalian circadian clock and metabolic homeostasis.
How it works: By binding Rev-Erb receptors, SR9009 upregulates the transcription of fatty acid and glucose oxidation genes, increasing mitochondrial density in skeletal muscle and driving resting metabolic expenditure.
Why researchers study it: Famous in preclinical exercise physiology for boosting running capacity, aerobic endurance, and energy expenditure in murine models without physical training.




